Pharma-Bio Serv, Inc. (PBSV)
OTCMKTS: PBSV · Delayed Price · USD
0.650
0.00 (0.00%)
Jul 23, 2024, 4:00 PM EDT - Market closed
Pharma-Bio Serv Employees
Pharma-Bio Serv had 100 employees as of October 31, 2023. The number of employees decreased by 40 or -28.57% compared to the previous year.
Employees
100
Change (1Y)
-40
Growth (1Y)
-28.57%
Revenue / Employee
$129,332
Profits / Employee
-$54
Market Cap
14.92M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
PBSV News
- 5 weeks ago - Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2024 - Accesswire
- 4 months ago - Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2024 - Accesswire
- 6 months ago - Pharma-Bio Serv Announces Full Year Results - Accesswire
- 7 months ago - Pharma-Bio Serv Announces Special Dividend - Accesswire
- 11 months ago - Pharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2023 - Accesswire
- 1 year ago - Pharma-Bio Serv Announces Results for the Three and Six Months Ended April 30, 2023 - Accesswire
- 1 year ago - Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2023 - Accesswire
- 1 year ago - Pharma-Bio Serv Retains Investment Banking Firm ACP Capital to Provide Investment Banking and M&A Advisory Services - Accesswire